Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry represents an uncharacterized RNA transcript annotated in genomic databases as "sense intronic to ITGB2 and SUMO3". It does not encode a recognized protein and lacks evidence for biological or clinical relevance. No information currently supports its classification as a functional gene product, disease marker, or therapeutic target[2]. The transcript is listed as "RNA gene" in GeneCards, further indicating it is not protein-coding and its biological role, if any, is not established. While ITGB2 and SUMO3 are well-known genes, ENSG00000306307 is distinct and does not directly encode or regulate these proteins[2]. Most alternatively spliced or intronic transcripts of SUMO3 discussed in the literature encode protein variants, but this entry is not associated with those characterized isoforms[1]. There is no evidence in the current peer-reviewed literature or major genomic references to support that ENSG00000306307 represents a druggable target, functional RNA, protein, or disease-related entity. Its status is most likely as an uncharacterized or non-functional transcript.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, sense intronic to ITGB2 and SUMO3 (ENSG00000306307).